Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 2Active not recruiting 2Unknown 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 12Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 5Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Ovarian Neoplasms 3Neoplasm Metastasis 3Fallopian Tube Neoplasms 3Advanced Pancreatic Cancer 3Esophageal Neoplasms 2Biliary Tract Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Staging IV NSCLC 1Squamous Cell Carcinoma of Lung 1Solid Tumor 1Sertoli-Leydig Cell Tumor 1Recurrence 1Peritoneal Neoplasms 1Pancreatic Cancer Non-resectable 1Pancreatic Adenocarcinoma 1Ovarian gynandroblastoma 1Obesity 1Neurotoxicity Syndromes 1Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Liver Neoplasms 1HER2-negative Breast Cancer 1HER2+ Breast Cancer 1

Interventions

Fluorouracil 5Radiotherapy 3Paclitaxel 3Leucovorin 3Endoscopy 3Cisplatin 3Oxaliplatin 2Neoadjuvant Therapy 2Endoscopy, Digestive System 2Endoscopic Mucosal Resection 2Carboplatin 2tremelimumab 1rucaparib 1rubitecan 1durvalumab 1Taxes 1Surveys and Questionnaires 1Ramucirumab 1Radiation 1Positron Emission Tomography Computed Tomography 1Nivolumab 1Microarray Analysis 1Magnetic Resonance Imaging 1Irinotecan 1High-Throughput Screening Assays 1Genetic Linkage 1Epirubicin 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Drug Therapy 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Adenocarcinoma Of Esophagus × Taxes × Clear all
NCT02037048 2024-01-08

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

Case Comprehensive Cancer Center

Phase 2 Unknown
63 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡